Dosing9 min readUpdated 2026-04-10

    Mounjaro Dosing Chart: Weekly Dose Schedule Explained

    See the Mounjaro dosing chart, including starting dose, escalation schedule, maintenance doses, and missed-dose guidance.

    Written by Trimi Medical Team. Medically reviewed by Dr. Asad Niazi, MD, MPH. This article covers the Mounjaro dosing chart including the starting dose, weekly escalation schedule, maintenance dosing, and missed-dose guidance.

    Quick links: Tirzepatide treatment, Zepbound dosing chart, and side effects timeline.

    Standard Mounjaro Dose Ladder

    The Mounjaro dosing chart follows a gradual escalation approach designed to improve tolerability while building toward an effective maintenance dose.

    Mounjaro Weekly Dose Progression

    Weeks 1-4: 2.5 mg once weekly. Weeks 5-8: 5 mg once weekly. Then, if needed, dose increases in 2.5 mg steps after at least 4 weeks on a given dose. Potential steps: 7.5 mg, 10 mg, 12.5 mg, 15 mg. Maintenance dosing is individualized.

    Why Mounjaro and Zepbound Charts Look Similar

    Readers often think Mounjaro and Zepbound must have very different dose structures because the brands are different. But because both products use tirzepatide, the dose-escalation logic is very similar. This makes understanding one chart helpful for understanding both.

    Why Escalation Takes Time

    Tirzepatide commonly causes gastrointestinal symptoms early in treatment, which is why the dose is usually increased gradually rather than aggressively. The dosing chart should not feel like a race.

    Start low at 2.5 mg to let the body adjust to the medication

    Increase carefully in 2.5 mg steps after at least 4 weeks per level

    Slow down if side effects get harder to manage at a given dose

    Stay longer at a tolerated dose if needed before advancing

    For a detailed look at what tirzepatide side effects look like over time, see our week-by-week guide.

    Maintenance Dosing Is Individualized

    Not everyone stays on the same endpoint dose. Some readers assume everyone should work their way up to the maximum dose, but that is not always true. The right maintenance dose depends on tolerability, appetite response, glycemic goals or weight-loss goals, and clinician guidance.

    For expected results at different timeframes, see our tirzepatide results after 3 months guide. And to understand what happens if you need to pause, read about what happens when you stop tirzepatide.

    Missed Dose and Schedule Consistency

    If you miss a Mounjaro dose, the official prescribing instructions matter. Doubling up or guessing can create avoidable problems. Contact your healthcare provider if you are unsure about what to do after a missed dose. Maintaining a consistent weekly injection schedule helps optimize treatment outcomes and minimize side effects.

    Frequently Asked Questions

    What is the starting dose for Mounjaro?

    Mounjaro is started at 2.5 mg once weekly for the first 4 weeks. This starting dose is intentionally low to allow the body to adjust to the medication and minimize gastrointestinal side effects. The 2.5 mg dose is not designed to produce maximum weight loss. It serves as an onboarding period.

    What does the Mounjaro dose escalation schedule look like?

    The standard progression starts at 2.5 mg once weekly for weeks 1 to 4, then increases to 5 mg once weekly for weeks 5 to 8. After that, the dose may rise in 2.5 mg increments after at least 4 weeks on a given dose, moving through 7.5 mg, 10 mg, 12.5 mg, and potentially 15 mg depending on tolerance and clinical response.

    Why are the Mounjaro and Zepbound dosing charts so similar?

    Both Mounjaro and Zepbound use tirzepatide as the active ingredient, which is why the dose-escalation logic is very similar. The brands are different and may be prescribed under different clinical contexts, but the underlying dose ladder follows the same principles of gradual titration to improve tolerability.

    Why does Mounjaro dose escalation take so long?

    The dose is usually increased gradually rather than aggressively because tirzepatide commonly causes gastrointestinal symptoms early in treatment. Side effects like nausea, diarrhea, and vomiting are more manageable when the body has time to adjust at each dose level. This is not a weakness of the medication but part of using it intelligently.

    Does everyone need to reach the maximum Mounjaro dose?

    No. Not everyone stays on the same endpoint dose. The right maintenance dose depends on tolerability, appetite response, glycemic goals or weight-loss goals, and clinician guidance. Some patients do well at 5 mg or 10 mg without needing to increase further. The chart should be interpreted as a framework, not a mandatory progression.

    What should I do if I miss a Mounjaro dose?

    If you miss a Mounjaro dose, follow the instructions in the prescribing information and your clinician's guidance. The exact timing of when you missed the dose matters, and doubling up or guessing can create avoidable problems. Contact your healthcare provider if you are unsure about what to do after a missed dose.

    How does Mounjaro dosing relate to side effects?

    Side effects are most common during the initial weeks of treatment and after dose increases. The gradual escalation schedule is designed specifically to help manage these effects. If side effects become difficult at a particular dose level, your clinician may recommend staying at that dose longer before increasing, or may adjust the plan based on your individual response.

    Sources & References

    1. Mounjaro prescribing information. FDA.
    2. Mounjaro patient information. Eli Lilly.

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, adjusting, or discontinuing any medication. Individual results vary. Dose adjustments should only be made under medical supervision. Mounjaro requires a prescription.

    What does the published clinical evidence show for compounded tirzepatide?

    Peer-reviewed evidence: Tirzepatide 15 mg produced a mean body weight reduction of approximately 22.5% at 72 weeks in adults with obesity without diabetes; the 5 mg and 10 mg doses produced 16.0% and 21.4% reductions respectively. (Source: SURMOUNT-1, NEJM 2022). Trimi offers compounded tirzepatide starting at $125/month on the annual plan, dispensed by 503A community sterile compounding pharmacies (VialsRx — Texas pharmacy license #35264 — and GreenwichRx). Results vary by individual; eligibility is determined by a licensed clinician.

    Tirzepatide 15 mg produced a mean body weight reduction of approximately 22.5% at 72 weeks in adults with obesity without diabetes; the 5 mg and 10 mg doses produced 16.0% and 21.4% reductions respectively. — SURMOUNT-1, NEJM 2022
    In a 40-week head-to-head trial of patients with type 2 diabetes, tirzepatide 15 mg produced approximately 11.2 kg of body-weight reduction vs 5.7 kg on semaglutide 1 mg. — SURPASS-2, NEJM 2021
    Tirzepatide reduced the apnea-hypopnea index by approximately 27 to 30 events/hour at 52 weeks in adults with obesity and moderate-to-severe obstructive sleep apnea, vs roughly 5 events/hour reduction on placebo. — SURMOUNT-OSA, NEJM 2024

    Key Takeaways

    • Tirzepatide 15 mg produced a mean body weight reduction of approximately 22.5% at 72 weeks in adults with obesity without diabetes; the 5 mg and 10 mg doses produced 16.0% and 21.4% reductions respectively. (Source: SURMOUNT-1, NEJM 2022)
    • In a 40-week head-to-head trial of patients with type 2 diabetes, tirzepatide 15 mg produced approximately 11.2 kg of body-weight reduction vs 5.7 kg on semaglutide 1 mg. (Source: SURPASS-2, NEJM 2021)
    • Tirzepatide reduced the apnea-hypopnea index by approximately 27 to 30 events/hour at 52 weeks in adults with obesity and moderate-to-severe obstructive sleep apnea, vs roughly 5 events/hour reduction on placebo. (Source: SURMOUNT-OSA, NEJM 2024)
    • Tirzepatide is the active pharmaceutical ingredient; it is FDA-approved in the corresponding brand finished products (Zepbound and Mounjaro). Trimi's compounded preparation of the same active ingredient is prepared per individual prescription by 503A community sterile compounding pharmacies and is not itself FDA-approved as a drug.
    • Eligibility requires evaluation by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Dose titration over weeks improves tolerability. Severe gastrointestinal symptoms may cause dehydration and increase acute kidney injury risk.
    • This is general information based on the cited evidence, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history, BMI, and comorbidities.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: April 10, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Amazing company and care team support! Fast response time, no hidden fees and they actually care enough to work with you and your needs on your weight loss journey. Down 12.5 pounds in 2 months!

    Outcome: Down 12.5 lbs in 2 months

    Sarah MillerFacebook
    Arrived within 24 hours. Easy to use. Comes with everything. The year is so worth it.

    Outcome: Same-day delivery experience

    Veronica LarimoreFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2206038
    2. Frías JP, Davies MJ, Rosenstock J, et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2107519
    3. Wadden TA, Chao AM, Machineni S, et al. (2023). Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial. Nature Medicine.Read StudyDOI: 10.1038/s41591-023-02597-w
    4. Aronne LJ, Sattar N, Horn DB, et al. (2024). Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA.Read StudyDOI: 10.1001/jama.2023.24945
    5. Malhotra A, Grunstein RR, Fietze I, et al. (2024). Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2404881
    6. U.S. Food and Drug Administration (2024). Zepbound (tirzepatide) Prescribing Information. FDA.Read Study

    Was this article helpful?

    Keep Reading

    Step-by-step retatrutide injection: 6-day half-life, once-weekly dosing, site rotation, and how to time shots for fewer side effects and better weight loss results.

    Start your GLP-1 journey — from $99/mo

    Get Started